BnR Summit 2026

Belt & Road Summit - Deal-Making 2026

9 – 15 Sept 2026 | Hong Kong, China (Hong Kong)

Nordia Biotech & Pharmaceuticals HK Limited

www.nordia.com.hkChina (Hong Kong)
8 profile visits

About

Nordia Biotech & Pharmaceuticals is a spin-off company from LKS Faculty of Medicine, HKU. It was founded on 2023.12, by Prof. ZHOU Zhongjun, the Chui Fook-Chuen Endowed Professor from HKUMed with over 30 years of experiences in development, aging and age-associated diseases, together with his former PhD student, HE Yi who developed the core technology. Our team members are very experienced in investment, financing, transformation and operation. Nordia Biotech finished its 7M HKD Series Angel led by HKX, started the 30M HKD Pre-A. We applied the projects of TSSSU+ and HKSTP Incu-Bio, and will receive support from them soon.

Areas of activity

Technology

Bio-TechHealth Technology

Additional information

Other Place of Business

Mainland China

Company Funding Stage

Seed & Pre-Series

Terms and Conditions & Disclaimer

I agree

Representatives

Founder

Nordia Biotech & Pharmaceuticals HK Limited

Marketplace (1)

  • Project

    Human Pluripotent Stem Cell-Derived Islet Organoid for Diabetes Treatment

    香港大学周中军教授团队开发3D胰岛类器官为糖尿病治疗带来革命性突破

    • Yes
    • Yes
    • Equity
    • Bio-Tech
    • Technology
    • Joint Venture
    • Private Project
    • Health Technology
    • Equity (private)
    • Medical Technology
    • Financial Services
    • Open for negotiation
    • Open for Negotiation
    • Direct Equity Investment
    • Institutional Investment
    • 5,000,001 to 7,500,000 USD
    • Feasibility Study Completed
    • 25,000,001 to 50,000,000 USD
    Author

    Founder at Nordia Biotech & Pharmaceuticals HK Limited

    China (Hong Kong)